STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3645 by analyst upside · 2026-06-27
DOC
Healthpeak Properties, Inc.
Real Estate · Market Cap $15B · P/E 65.3x
ANALYST PRICE TARGET
-0.5%
implied upside to consensus target
Current Price $21.55
Consensus Target $21.44
Bull Target $29.0
Bear Target $17.0
Analysts Covering 18
ANALYST CONSENSUS — BUY
Strong Buy
3
Buy
7
Hold
8
Sell
0
52-Week Low $15.7
52-Week High $21.55
YTD Return +37.7%
FUNDAMENTALS
Market Cap $15B
P/E Ratio (TTM) 65.3x
Forward P/E 143.7x
EPS (TTM) $0.33
PEG Ratio 4.32
Dividend Yield 5.66%
Revenue (TTM) $2.9B
Profit Margin 7.7%
52-WEEK RANGE
52-Week Low $15.7
52-Week High $21.55
Current Price $21.55
Bear Target $17.0
Bull Target $29.0
● Now $21.55 ● Target $21.44
TRADING DATA
Avg Volume 9.0M
YTD Return +37.7%
Analyst Count 18
Consensus Buy
Upside to Target -0.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Healthpeak Properties, Inc. (DOC) is currently trading at $21.55 with a Wall Street consensus price target of $21.44, which is 0.5% below the current price over the next 12 months. 18 analysts currently cover DOC, with a consensus rating of Buy — 56% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $29.0, while the most cautious has a target of $17.0.

DOC operates in the Real Estate sector with a market capitalisation of $15B. The stock is up 37.7% year-to-date and is currently trading near the upper end of its 52-week range of $15.7 – $21.55.

SIMILAR STOCKS

Other Real Estate stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for DOC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BMO Capital — Reiterated
Outperform → Outperform 2026-06-15 Building track record
Morgan Stanley ↓ Downgrade
Overweight → Equal-Weight 2026-06-11 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-06-01 Building track record
Scotiabank — Reiterated
Sector Perform → Sector Perform 2026-05-27 20% win rate (5 calls)
Morgan Stanley — Reiterated
Overweight → Overweight 2026-05-22 Building track record
RBC Capital — Reiterated
Outperform → Outperform 2026-05-14 Building track record
UBS — Reiterated
Neutral → Neutral 2026-05-13 33% win rate (6 calls)
Baird — Reiterated
Outperform → Outperform 2026-05-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →